Xiamen Amoytop Biotech Hits Day Low Amid Price Pressure, Shares at CNY 58.04

Xiamen Amoytop Biotech Co. experienced a notable decline today, with the stock dropping by 4.33% as it reached an intraday low of CNY 58.04. This performance contrasts sharply with the China Shanghai Composite, which saw a modest decrease of 0.33% on the same day. Over the past week, Xiamen Amoytop has faced a significant downturn, with a 9.44% drop, and its monthly performance reflects a decline of 10.9%. Year-to-date, the stock has underperformed considerably, showing a decrease of 30.09%, while the broader market has gained 2.8%. Despite these recent challenges, the company has reported positive results for the last 18 consecutive quarters, with net sales reaching CNY 1,216.02 million and an operating profit of CNY 472.2 million. The company maintains a strong return on equity of 34.50% and a high dividend yield of 0.86%. However, it has underperformed the market over the past year, generating negative returns of 9.14% compared to the China Shanghai Composite's impressive 22.49% return.